Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2013; 19(38): 6438-6446
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6438
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6438
Table 1 Results of HER2 immunostaining using the three antibodies on whole-tissue sections and tissue microarrays n (%)
| Score | Whole-tissue sections | TMAs | ||||
| HercepTest | 4B5 | SP3 | HercepTest | 4B5 | SP3 | |
| 0 | 179 (90.9) | 125 (63.1) | 128 (65.2) | 185 (93.5) | 174 (88.8) | 162 (82.6) |
| 1+ | 7 (3.5) | 30 (15.2) | 17 (8.5) | 3 (1.5) | 10 (5.1) | 8 (4.1) |
| 2+ | 1 (0.5) | 20 (10.1) | 34 (17.2) | 4 (2.0) | 3 (1.5) | 15 (7.7) |
| 3+ | 10 (5.1) | 23 (11.6) | 18 (9.1) | 6 (3.0) | 9 (4.6) | 11 (5.6) |
| Total | 197 (100.0) | 198 (100.0) | 197 (100.0) | 198 (100.0) | 196 (100.0) | 196 (100.0) |
- Citation: Abrahão-Machado LF, Jácome AADA, Wohnrath DR, Santos JSD, Carneseca EC, Fregnani JHTG, Scapulatempo-Neto C. HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays. World J Gastroenterol 2013; 19(38): 6438-6446
- URL: https://www.wjgnet.com/1007-9327/full/v19/i38/6438.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i38.6438